Neonatal Jaundice — MCCQE1 Clinical Presentation Guide 2026

About This Page

This is a clinician-written, evidence-based guide aligned to the MCC Examination Objectives. It is structured by clinical presentation — the way the MCCQE tests and the way patients actually present. Management reflects current Canadian guidelines (CMA, CFPC, CPS). Always cross-reference with institutional protocols and clinical judgment.

Key points

Neonatal Jaundice is managed by first identifying emergency red flags before considering benign explanations
Use the child’s age, appearance, hydration/perfusion, growth/development, and caregiver context to structure the differential
The differential diagnosis table is the centrepiece: rule out must-not-miss diagnoses before common self-limited causes
Investigations should be targeted rather than broad; avoid low-value tests when the child is well and the pattern is clear
Management combines stabilization, cause-specific treatment, safety-netting, and family-centred communication

Approach to the Presentation

Neonatal Jaundice is approached as a paediatric clinical presentation rather than a single diagnosis. The first task is to decide whether the child is unstable or has a red flag. The second is to use age, trajectory, associated symptoms, examination, growth/development, and family context to prioritize must-not-miss diagnoses. Canadian practice should align with CPS, PHAC/NACI, Choosing Wisely Canada, and local provincial/territorial pathways where relevant. Neonatal jaundice is common but time-sensitive — the priority is identifying early, severe, conjugated, or haemolytic jaundice before bilirubin neurotoxicity occurs

Differential Diagnosis

diagnosis	likelihood	key features	distinguishing test
Haemolytic Disease of the Newborn	must-not-miss	Jaundice within 24h, rapid bilirubin rise, anaemia, ABO/Rh incompatibility	Blood type, DAT, CBC/reticulocytes
Acute Bilirubin Encephalopathy	must-not-miss	Lethargy, poor feeding, abnormal tone, high-pitched cry, seizures	Urgent serum bilirubin
Neonatal Sepsis	must-not-miss	Jaundice with temperature instability, poor feeding, lethargy, poor perfusion	Sepsis workup and empiric antibiotics
Biliary Atresia / Cholestasis	must-not-miss	Persistent jaundice >2 weeks, pale stools, dark urine, hepatomegaly	Fractionated bilirubin, LFTs/GGT, ultrasound
Physiologic Jaundice	common	After 24h, peaks day 3-5 in term infant, well baby	Bilirubin plotted by age in hours
Suboptimal Intake Jaundice	common	First week, poor intake, weight loss, reduced stools/urine	Feeding assessment and bilirubin
Breast Milk Jaundice	common	Thriving breastfed infant with prolonged unconjugated jaundice	Diagnosis of exclusion
G6PD Deficiency	less common	Severe/early jaundice, family/ethnic risk, haemolysis	G6PD level
Cephalohaematoma / Bruising	less common	Birth trauma, scalp swelling/bruising	Exam and bilirubin monitoring
Congenital Hypothyroidism	rare	Prolonged jaundice, lethargy, constipation, macroglossia	Newborn screen, TSH/free T4

Red Flags & Key History

Symptoms

Jaundice in the first 24 hours

Poor feeding, lethargy, high-pitched cry, abnormal tone, seizures

Dark urine or pale/acholic stools

Persistent jaundice beyond 2 weeks

Prematurity, significant bruising, cephalohaematoma

Maternal-neonatal blood group incompatibility

Typical mild symptoms in a well child with normal hydration/perfusion and reliable follow-up

Signs

Toxic appearance, altered responsiveness, poor perfusion, or respiratory distress

Abnormal growth, hydration, neurological, abdominal, skin, or musculoskeletal findings

Focal signs that localize infection, surgical disease, trauma, or inflammatory disease

Findings inconsistent with the history or developmental stage

Normal examination with stable course and clear benign pattern

Approach to Investigation

First-line

Transcutaneous or total serum bilirubinFirst-line assessment for this presentation; interpret in clinical context

Fractionated bilirubin if prolonged or cholestasis suspectedHigh-yield initial test or examination component

Feeding, weight loss, urine/stool assessmentUse when red flags, dehydration, systemic illness, or diagnostic uncertainty are present

Blood group, DAT, CBC/reticulocytesTargeted testing rather than broad screening whenever the child is stable

Second-line

Focused imaging or advanced testingUse when first-line assessment suggests surgical, neurological, infectious, inflammatory, or structural disease

Microbiology or serologyUse when public health, infection control, travel, outbreak, immunocompromise, or treatment decisions depend on organism identification

Serial reassessmentImportant when early disease may not yet declare itself

Targeted screening for mimicsUse when presentation is persistent, recurrent, atypical, or associated with poor growth/development

Specialist

Paediatrics or emergency specialistFor unstable child, diagnostic uncertainty, admission need, or high-risk features

Subspecialty consultationSurgery, neurology, infectious diseases, gastroenterology, nephrology, endocrinology, child protection, or public health depending on presentation

Management Principles

Canadian Paediatric Society neonatal hyperbilirubinaemia guidance

Immediate priorities

Assess ABCs, vital signs, hydration/perfusion, pain, glucose when relevant, and need for urgent escalation
Treat shock, hypoxia, seizures, severe dehydration, suspected sepsis, or surgical abdomen without delay
Use age-appropriate analgesia and family-centred communication

Targeted management

Treat the most likely or confirmed cause using Canadian/local guidance
Avoid low-value investigations and therapies in typical benign presentations
Arrange appropriate follow-up, reassessment, and return precautions

Family and safety-netting

Explain expected course, red flags, and when to return
Assess caregiver capacity, access to fluids/medications/transport, and social supports
Escalate safeguarding concerns according to provincial/territorial law

Complications & Pitfalls

Premature closure: do not diagnose a benign condition before red flags are excluded.
Age-blind assessment: neonates, infants, school-aged children, and adolescents have different risks.
Low-value testing: broad testing can distract from careful history, examination, and targeted investigation.
Poor safety-netting: discharge requires explicit return precautions and reliable follow-up.

MCCQE1 Exam Tips

1Jaundice in the first 24 hours is pathologic
2Measure bilirubin objectively and plot by age in hours
3Pale stools plus dark urine means conjugated jaundice/biliary atresia
4DAT-positive anaemia suggests immune haemolysis
5Kernicterus clues are lethargy, high-pitched cry, abnormal tone, arching, seizures
6Breast milk jaundice is a diagnosis of exclusion
7Parents need clear follow-up because bilirubin peaks after discharge

Put your reading into practice

Checking available topic practice…

Choose MCCQE Part I questions from the existing bank. General exam practice covers your selected topics; it is not filtered to this article. Your usual question-bank access applies.

Choose MCCQE Part I practice

After your session, return to this section to revisit the reading and choose your next review.

regional clinical guidance